COVID-19 Vaccine: Pfizer Less Effective In South African Variant

Some health concerns now, a real-world study out of Israel has suggested that the South African variant of COVID-19 could possibly 'break through' Pfizer/BioNTech's vaccine, though researchers cautioned that the sample size was small owing to its rarity in the country and that the study had also not been peer-reviewed.